Clinical trial
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation…
NCT00031798 · Wake Forest University Health Sciences, Other · Terminated
Key facts
| NCT number | NCT00031798 |
|---|---|
| Title | Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors |
| Official title | A Phase III, Double-Blind, Prospective Randomized Clinical Trial of the Effect of D-threo-methylphenidate HCl (d-MPH) on Quality of Life in Brain Tumor Patients Receiving Radiation Therapy |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Depression, Fatigue, Quality of Life |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | methylphenidate hydrochloride, quality-of-life assessment, radiation therapy |
| Start date | Apr 1, 2002 |
| Primary completion | Mar 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 9, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: